Olivia Newton-John Cancer Research Institute

Organization name
Olivia Newton-John Cancer Research Institute
Parent OrgUnit
City
Heidelberg, Victoria
Country
Australia


Results 441-460 of 755 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
44126-Apr-2019Oncogenic mutations at the EGFR ectodomain structurally converge to remove a steric hindrance on a kinase-coupled cryptic epitope.Orellana, Laura; Thorne, Amy H; Lema, Rafael; Gustavsson, Johan; Parisian, Alison D; Hospital, Adam; Cordeiro, Tiago N; Bernadó, Pau; Scott, Andrew M ; Brun-Heath, Isabelle; Lindahl, Erik; Cavenee, Webster K; Furnari, Frank B; Orozco, Modesto
44224-Apr-2019Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer.Merino, Delphine; Weber, T S; Serrano, A; Vaillant, F; Liu, K; Pal, B; Di Stefano, L; Schreuder, J; Lin, D; Chen, Y; Asselin-Labat, M L; Schumacher, T N; Cameron, D; Smyth, G K; Papenfuss, A T; Lindeman, G J; Visvader, J E; Naik, S H
44316-Apr-2019Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients.Mithraprabhu, Sridurga; Morley, Rachel; Khong, Tiffany; Kalff, Anna; Bergin, Krystal; Hocking, Jay; Savvidou, Ioanna; Bowen, Kathryn M; Ramachandran, Malarmathy; Choi, Kawa; Wong, Boris Ka Leong; Reynolds, John; Spencer, Andrew
444Apr-2019TERT gene: its function and dysregulation in cancer.Colebatch, Andrew J; Dobrovic, Alexander ; Cooper, Wendy A
445Apr-2019Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.Rivalland, Gareth; Mitchell, Paul L R ; Murone, Carmel ; Asadi, Khashayer; Morey, Adrienne L; Starmans, Maud; Boutros, Paul C; Walkiewicz, Marzena; Solomon, Benjamin; Wright, Gavin; Knight, Simon; John, Thomas 
446Apr-2019Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2.Barlesi, F; Drilon, A; De Braud, F; Cho, B C; Ahn, M J; Siena, S; Krebs, M G; Lin, C C; John, Thomas ; Tan, D S W; Seto, T; Dziadziuszko, R; Arkenau, H-T; Rolfo, C; Wolf, J; Ye, C; Riehl, T; Eng, S; Doebele, R C
447Apr-2019Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth.Thilakasiri, Pathum; Huynh, Jennifer; Poh, Ashleigh R; Tan, Chin Wee; Nero, Tracy L; Tran, Kelly; Parslow, Adam C; Afshar-Sterle, Shoukat ; Baloyan, David; Hannan, Natalie J; Buchert, Michael; Scott, Andrew M ; Griffin, Michael D W; Hollande, Frederic; Parker, Michael W; Putoczki, Tracy L; Ernst, Matthias ; Chand, Ashwini L 
448Apr-2019Synchrotron microbeam radiotherapy evokes a different early tumor immunomodulatory response to conventional radiotherapy in EMT6.5 mammary tumors.Yang, Yuqing; Swierczak, Agnieszka; Ibahim, Mohammad; Paiva, Premila; Cann, Leonie; Stevenson, Andrew W; Crosbie, Jeffrey C; Anderson, Robin L ; Rogers, Peter A W
449Apr-2019Osimertinib as first-line (1L) treatment for epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC): Final efficacy and safety results from two phase I expansion cohorts.Yang, J C-H; Ramalingam, S S; Lee, C K; Kurata, T; Kim, D-W; John, Thomas ; Nogami, N; Ohe, Y; Rukazenkov, Y; Murphy, M; Jänne, P A
450Apr-2019Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001.Paz-Ares, L; Doebele, R C; Farago, A F; Liu, S V; Chawla, S P; Tosi, D; Blakely, C M; Krauss, J C; Sigal, D; Bazhenova, L; John, Thomas ; Besse, B; Wolf, J; Seto, T; Chow-Maneval, E; Ye, C; Simmons, B; Demetri, G D
45127-Mar-2019Epidermal growth factor receptor (EGFR)-targeted therapies in Mesothelioma.Chia, Puey Ling ; Scott, Andrew M ; John, Thomas 
4521-Mar-2019Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations.Flanagan, Dustin J; Barker, Nick; Costanzo, Natasha S Di; Mason, Elizabeth A; Gurney, Austin; Meniel, Valerie S; Koushyar, Sarah; Austin, Chloe R; Ernst, Matthias ; Pearson, Helen B; Boussioutas, Alex; Clevers, Hans; Phesse, Toby J; Vincan, Elizabeth
453Mar-2019A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer.Lok, Sheau W; Whittle, James R; Vaillant, François; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria João; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Bujak, Andjelija Zivanovic; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E; Lindeman, Geoffrey J
454Mar-2019Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.Casan, Joshua Ml; Barraclough, Allison ; Shortt, Jake; Hawkes, Eliza A 
455Mar-2019Primary transitional cell carcinoma of penis - A rare presentation.Teh, Jiasian ; Kearns, Paul; Lawrentschuk, Nathan
456Mar-2019Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.Williams, David S ; Mouradov, Dmitri; Jorissen, Robert N; Newman, Marsali R ; Amini, Elham; Nickless, David K; Teague, Julie A; Fang, Catherine G; Palmieri, Michelle; Parsons, Marie J; Sakthianandeswaren, Anuratha; Li, Shan; Ward, Robyn L; Hawkins, Nicholas J; Faragher, Ian; Jones, Ian T; Gibbs, Peter; Sieber, Oliver M
45726-Feb-2019Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer.Wiegmans, Adrian P; Saunus, Jodi M; Ham, Sunyoung; Lobb, Richard; Kutasovic, Jamie R; Dalley, Andrew J; Miranda, Mariska; Atkinson, Caroline; Foliaki, Simote T; Ferguson, Kaltin; Niland, Colleen; Johnstone, Cameron N ; Lewis, Victoria; Collins, Steven J; Lakhani, Sunil R; Al-Ejeh, Fares; Möller, Andreas
45815-Feb-2019Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer.Merino, Delphine; Weber, T S; Serrano, A; Vaillant, F; Liu, K; Pal, B; Di Stefano, L; Schreuder, J; Lin, D; Chen, Y; Asselin-Labat, M L; Schumacher, T N; Cameron, D; Smyth, G K; Papenfuss, A T; Lindeman, G J; Visvader, J E; Naik, S H
45914-Feb-2019Molecular genomic profiling of melanocytic nevi.Colebatch, Andrew J; Ferguson, Peter; Newell, Felicity; Kazakoff, Stephen H; Witkowski, Tom ; Dobrovic, Alexander ; Johansson, Peter A; Saw, Robyn Pm; Stretch, Jonathan R; McArthur, Grant A; Long, Georgina V; Thompson, John F; Pearson, John V; Mann, Graham J; Hayward, Nicholas K; Waddell, Nicola; Scolyer, Richard A; Wilmott, James S
4607-Feb-2019Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases.Yap, May Lin; McFadyen, James D; Wang, Xiaowei; Ziegler, Melanie; Chen, Yung-Chih; Willcox, Abbey ; Nowell, Cameron J; Scott, Andrew M ; Sloan, Erica K; Hogarth, P Mark; Pietersz, Geoffrey A; Peter, Karlheinz